AMERICAN INTERNATIONAL GROUP, INC. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$46,000
+17.9%
34,166
-1.7%
0.00%
Q4 2018$39,000
-59.8%
34,768
-0.8%
0.00%
Q3 2018$97,000
-19.2%
35,035
+4.3%
0.00%
Q2 2018$120,000
+18.8%
33,604
+2.2%
0.00%
Q1 2018$101,000
-53.2%
32,892
-4.1%
0.00%
-100.0%
Q4 2017$216,000
-6.5%
34,298
+1.4%
0.00%0.0%
Q3 2017$231,000
+38.3%
33,826
+44.1%
0.00%0.0%
Q2 2017$167,000
-18.9%
23,481
+4.9%
0.00%0.0%
Q1 2017$206,000
+145.2%
22,390
+7.1%
0.00%
Q4 2016$84,000
-99.9%
20,904
-0.3%
0.00%
Q3 2016$80,269,000
-10.8%
20,958
+0.2%
0.00%
Q2 2016$89,982,000
-13.5%
20,926
-7.0%
0.00%
Q1 2016$104,000,000
-53.8%
22,4950.0%0.00%
-100.0%
Q4 2015$225,000,000
+133828.6%
22,495
-0.2%
0.00%0.0%
Q3 2015$168,000
-100.0%
22,532
+0.1%
0.00%
-75.0%
Q2 2015$1,067,732,000
+64.3%
22,507
+26.9%
0.00%
+33.3%
Q1 2015$649,774,000
-7.7%
17,7340.0%0.00%0.0%
Q4 2014$704,217,000
+129.0%
17,734
+15.1%
0.00%
+200.0%
Q3 2014$307,469,000
+47.8%
15,412
-0.1%
0.00%0.0%
Q2 2014$208,056,000
+100.3%
15,423
+61.7%
0.00%
Q1 2014$103,869,000
-17.5%
9,538
+2.5%
0.00%
-100.0%
Q4 2013$125,858,000
+43.2%
9,309
+20.6%
0.00%
Q3 2013$87,865,0007,7210.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,048,642$3,219,0000.50%
Virtus ETF Advisers LLC 130,920$402,0000.35%
683 Capital Management, LLC 600,000$1,842,0000.16%
Tekla Capital Management LLC 859,322$2,638,0000.10%
DOW CHEMICAL CO /DE/ 65,000$200,0000.07%
Alambic Investment Management, L.P. 115,834$356,0000.05%
A.R.T. Advisors, LLC 262,896$807,0000.03%
Candriam S.C.A. 520,613$1,598,0000.03%
Man Group plc 1,674,341$5,140,0000.02%
Baker Brothers Advisors 935,000$2,870,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders